$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.81 | 95 | 7,012 | 209,679 | 209.8 K to 209.7 K (-0.05 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 18,604 | 1,410,758 | 9,922,941 | 9.9 M to 9.9 M (-0.19 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 2,856 | 216,573 | 1,557,676 | 1.6 M to 1.6 M (-0.18 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 492 | 37,309 | 301,954 | 302.4 K to 302 K (-0.16 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 286 | 21,688 | 192,095 | 192.4 K to 192.1 K (-0.15 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 21 | 1,592 | 51,966 | 52 K to 52 K (-0.04 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.83 | 319 | 24,190 | 209,774 | 210.1 K to 209.8 K (-0.15 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 371 | 28,608 | 9,941,545 | 9.9 M to 9.9 M (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 57 | 4,395 | 1,560,532 | 1.6 M to 1.6 M (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 10 | 771 | 302,446 | 302.5 K to 302.4 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 6 | 463 | 192,381 | 192.4 K to 192.4 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 1 | 77 | 51,987 | 52 K to 52 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.11 | 6 | 463 | 210,093 | 210.1 K to 210.1 K (0.00 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 33,772 | |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 75.72 | 1,104 | 83,595 | 17,763 | 18.9 K to 17.8 K (-5.85 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 75.29 | 1,596 | 120,168 | 18,867 | 20.5 K to 18.9 K (-7.80 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 73.75 | 300 | 22,126 | 20,463 | 20.8 K to 20.5 K (-1.44 %) |
| Dec 07 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 20,763 | 17.8 K to 20.8 K (+16.89 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 17.33 | 1,500 | 25,995 | 0 | |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 80.40 | 200 | 16,079 | 336,741 | 336.9 K to 336.7 K (-0.06 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 78.60 | 100 | 7,860 | 336,941 | 337 K to 336.9 K (-0.03 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 77.93 | 1,087 | 84,715 | 337,041 | 338.1 K to 337 K (-0.32 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 76.28 | 113 | 8,619 | 338,128 | 338.2 K to 338.1 K (-0.03 %) |
| Dec 06 2018 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 17.33 | 1,500 | 25,995 | 338,241 | 336.7 K to 338.2 K (+0.45 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 247 | 18,925 | 9,941,916 | 9.9 M to 9.9 M (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 38 | 2,911 | 1,560,589 | 1.6 M to 1.6 M (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 6 | 460 | 302,456 | 302.5 K to 302.5 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 4 | 306 | 192,387 | 192.4 K to 192.4 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 1 | 77 | 51,988 | 52 K to 52 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.62 | 4 | 306 | 210,099 | 210.1 K to 210.1 K (0.00 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 32,598 | 2,527,147 | 9,942,163 | 10 M to 9.9 M (-0.33 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 5,005 | 388,011 | 1,560,627 | 1.6 M to 1.6 M (-0.32 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 863 | 66,904 | 302,462 | 303.3 K to 302.5 K (-0.28 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 500 | 38,762 | 192,391 | 192.9 K to 192.4 K (-0.26 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 38 | 2,946 | 51,989 | 52 K to 52 K (-0.07 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.52 | 559 | 43,336 | 210,103 | 210.7 K to 210.1 K (-0.27 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 89,047 | 6,950,074 | 9,974,761 | 10.1 M to 10 M (-0.88 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 13,671 | 1,067,015 | 1,565,632 | 1.6 M to 1.6 M (-0.87 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 2,357 | 183,963 | 303,325 | 305.7 K to 303.3 K (-0.77 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 1,367 | 106,694 | 192,891 | 194.3 K to 192.9 K (-0.70 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 104 | 8,117 | 52,027 | 52.1 K to 52 K (-0.20 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.05 | 1,526 | 119,104 | 210,662 | 212.2 K to 210.7 K (-0.72 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 44,659 | 3,576,721 | 10,063,808 | 10.1 M to 10.1 M (-0.44 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 6,856 | 549,094 | 1,579,303 | 1.6 M to 1.6 M (-0.43 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 1,182 | 94,666 | 305,682 | 306.9 K to 305.7 K (-0.39 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 685 | 54,861 | 194,258 | 194.9 K to 194.3 K (-0.35 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 52 | 4,165 | 52,131 | 52.2 K to 52.1 K (-0.10 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 765 | 61,269 | 212,188 | 213 K to 212.2 K (-0.36 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 129,121 | 10,209,675 | 10,108,467 | 10.2 M to 10.1 M (-1.26 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 19,824 | 1,567,496 | 1,586,159 | 1.6 M to 1.6 M (-1.23 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 3,417 | 270,184 | 306,864 | 310.3 K to 306.9 K (-1.10 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 1,981 | 156,639 | 194,943 | 196.9 K to 194.9 K (-1.01 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 151 | 11,940 | 52,183 | 52.3 K to 52.2 K (-0.29 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.07 | 2,214 | 175,062 | 212,953 | 215.2 K to 213 K (-1.03 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 39,591 | 3,152,536 | 10,237,588 | 10.3 M to 10.2 M (-0.39 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 6,078 | 483,977 | 1,605,983 | 1.6 M to 1.6 M (-0.38 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 1,048 | 83,450 | 310,281 | 311.3 K to 310.3 K (-0.34 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 608 | 48,414 | 196,924 | 197.5 K to 196.9 K (-0.31 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 46 | 3,663 | 52,334 | 52.4 K to 52.3 K (-0.09 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.63 | 678 | 53,988 | 215,167 | 215.8 K to 215.2 K (-0.31 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 30,257 | 2,348,376 | 10,277,179 | 10.3 M to 10.3 M (-0.29 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 4,646 | 360,596 | 1,612,061 | 1.6 M to 1.6 M (-0.29 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 801 | 62,169 | 311,329 | 312.1 K to 311.3 K (-0.26 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 465 | 36,091 | 197,532 | 198 K to 197.5 K (-0.23 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 35 | 2,717 | 52,380 | 52.4 K to 52.4 K (-0.07 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.61 | 518 | 40,204 | 215,845 | 216.4 K to 215.8 K (-0.24 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 11,994 | 945,149 | 10,307,436 | 10.3 M to 10.3 M (-0.12 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 1,841 | 145,074 | 1,616,707 | 1.6 M to 1.6 M (-0.11 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 317 | 24,980 | 312,130 | 312.4 K to 312.1 K (-0.10 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 184 | 14,500 | 197,997 | 198.2 K to 198 K (-0.09 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 14 | 1,103 | 52,415 | 52.4 K to 52.4 K (-0.03 %) |
| Dec 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.80 | 206 | 16,233 | 216,363 | 216.6 K to 216.4 K (-0.10 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 77,976 | 5,989,017 | 10,319,430 | 10.4 M to 10.3 M (-0.75 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 11,972 | 919,520 | 1,618,548 | 1.6 M to 1.6 M (-0.73 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 2,064 | 158,527 | 312,447 | 314.5 K to 312.4 K (-0.66 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 1,197 | 91,937 | 198,181 | 199.4 K to 198.2 K (-0.60 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 91 | 6,989 | 52,429 | 52.5 K to 52.4 K (-0.17 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 1,335 | 102,536 | 216,569 | 217.9 K to 216.6 K (-0.61 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 13,595 | 1,006,150 | 10,397,406 | 10.4 M to 10.4 M (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 2,087 | 154,456 | 1,630,520 | 1.6 M to 1.6 M (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 360 | 26,643 | 314,511 | 314.9 K to 314.5 K (-0.11 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 209 | 15,468 | 199,378 | 199.6 K to 199.4 K (-0.10 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 16 | 1,184 | 52,520 | 52.5 K to 52.5 K (-0.03 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 233 | 17,244 | 217,904 | 218.1 K to 217.9 K (-0.11 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 57,979 | 4,331,524 | 10,411,001 | 10.5 M to 10.4 M (-0.55 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 8,901 | 664,980 | 1,632,607 | 1.6 M to 1.6 M (-0.54 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 1,534 | 114,603 | 314,871 | 316.4 K to 314.9 K (-0.48 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 890 | 66,491 | 199,587 | 200.5 K to 199.6 K (-0.44 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 68 | 5,080 | 52,536 | 52.6 K to 52.5 K (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 994 | 74,260 | 218,137 | 219.1 K to 218.1 K (-0.45 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 56,764 | 4,272,831 | 10,468,980 | 10.5 M to 10.5 M (-0.54 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 8,715 | 656,009 | 1,641,508 | 1.7 M to 1.6 M (-0.53 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 1,502 | 113,061 | 316,405 | 317.9 K to 316.4 K (-0.47 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 871 | 65,563 | 200,477 | 201.3 K to 200.5 K (-0.43 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 66 | 4,968 | 52,604 | 52.7 K to 52.6 K (-0.13 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 973 | 73,241 | 219,131 | 220.1 K to 219.1 K (-0.44 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 36,652 | 2,703,294 | 10,525,744 | 10.6 M to 10.5 M (-0.35 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 5,627 | 415,023 | 1,650,223 | 1.7 M to 1.7 M (-0.34 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 970 | 71,543 | 317,907 | 318.9 K to 317.9 K (-0.30 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 563 | 41,524 | 201,348 | 201.9 K to 201.3 K (-0.28 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 43 | 3,171 | 52,670 | 52.7 K to 52.7 K (-0.08 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 628 | 46,319 | 220,104 | 220.7 K to 220.1 K (-0.28 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 77,558 | 5,758,092 | 10,562,396 | 10.6 M to 10.6 M (-0.73 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 11,907 | 884,004 | 1,655,850 | 1.7 M to 1.7 M (-0.71 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 2,052 | 152,345 | 318,877 | 320.9 K to 318.9 K (-0.64 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 1,190 | 88,348 | 201,911 | 203.1 K to 201.9 K (-0.59 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 91 | 6,756 | 52,713 | 52.8 K to 52.7 K (-0.17 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 1,329 | 98,668 | 220,732 | 222.1 K to 220.7 K (-0.60 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 8,204 | 607,484 | 10,639,954 | 10.6 M to 10.6 M (-0.08 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 1,260 | 93,300 | 1,667,757 | 1.7 M to 1.7 M (-0.08 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 217 | 16,068 | 320,929 | 321.1 K to 320.9 K (-0.07 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 126 | 9,330 | 203,101 | 203.2 K to 203.1 K (-0.06 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 10 | 740 | 52,804 | 52.8 K to 52.8 K (-0.02 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 141 | 10,441 | 222,061 | 222.2 K to 222.1 K (-0.06 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 24,487 | 1,820,848 | 10,648,158 | 10.7 M to 10.6 M (-0.23 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 3,759 | 279,518 | 1,669,017 | 1.7 M to 1.7 M (-0.22 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 648 | 48,185 | 321,146 | 321.8 K to 321.1 K (-0.20 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 376 | 27,959 | 203,227 | 203.6 K to 203.2 K (-0.18 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 28 | 2,082 | 52,814 | 52.8 K to 52.8 K (-0.05 %) |
| Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 419 | 31,157 | 222,202 | 222.6 K to 222.2 K (-0.19 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 55,365 | 4,227,024 | 10,672,645 | 10.7 M to 10.7 M (-0.52 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 8,499 | 648,884 | 1,672,776 | 1.7 M to 1.7 M (-0.51 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 1,466 | 111,927 | 321,794 | 323.3 K to 321.8 K (-0.45 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 850 | 64,896 | 203,603 | 204.5 K to 203.6 K (-0.42 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 65 | 4,963 | 52,842 | 52.9 K to 52.8 K (-0.12 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 949 | 72,455 | 222,621 | 223.6 K to 222.6 K (-0.42 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 16,646 | 1,292,763 | 10,728,010 | 10.7 M to 10.7 M (-0.15 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 2,556 | 198,504 | 1,681,275 | 1.7 M to 1.7 M (-0.15 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 440 | 34,171 | 323,260 | 323.7 K to 323.3 K (-0.14 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 255 | 19,804 | 204,453 | 204.7 K to 204.5 K (-0.12 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 19 | 1,476 | 52,907 | 52.9 K to 52.9 K (-0.04 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 285 | 22,134 | 223,570 | 223.9 K to 223.6 K (-0.13 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 77.93 | 946 | 73,720 | 166,982 | 167.9 K to 167 K (-0.56 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 77.11 | 3,199 | 246,685 | 167,928 | 171.1 K to 167.9 K (-1.87 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 76.31 | 5,855 | 446,766 | 171,127 | 177 K to 171.1 K (-3.31 %) |
| Nov 20 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,860 | 0 | 57,657 | 59.5 K to 57.7 K (-3.13 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 22.98 | 15,000 | 344,700 | 0 | |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 22.98 | 25,000 | 574,500 | 15,000 | |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 77.91 | 1,400 | 109,067 | 176,982 | 178.4 K to 177 K (-0.78 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 77.10 | 4,939 | 380,814 | 178,382 | 183.3 K to 178.4 K (-2.69 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 76.31 | 8,661 | 660,912 | 183,321 | 192 K to 183.3 K (-4.51 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 22.98 | 15,000 | 344,700 | 191,982 | 177 K to 192 K (+8.48 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 78.69 | 10,083 | 793,390 | 176,982 | 187.1 K to 177 K (-5.39 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 77.56 | 2,854 | 221,349 | 187,065 | 189.9 K to 187.1 K (-1.50 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 76.89 | 5,138 | 395,072 | 189,919 | 195.1 K to 189.9 K (-2.63 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 75.78 | 1,925 | 145,880 | 195,057 | 197 K to 195.1 K (-0.98 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 74.77 | 5,000 | 373,870 | 196,982 | 202 K to 197 K (-2.48 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 22.98 | 25,000 | 574,500 | 201,982 | 177 K to 202 K (+14.13 %) |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 22.98 | 15,000 | 344,700 | 0 | |
| Nov 19 2018 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 22.98 | 25,000 | 574,500 | 15,000 |